At Virupaksha, delivering excellence in pharmaceutical manufacturing is not just a goal; it’s an unwavering commitment to quality and innovation. Renowned for producing high-purity Fluconazole, our facilities are meticulously crafted to meet the stringent standards set by WHO-GMP, ensuring that every batch reflects our dedication to global health. Our adherence to ISO 9001 guarantees that we maintain a robust quality management system, while ISO 14001 highlights our commitment to environmentally sustainable practices throughout the production process.
This meticulous attention to detail is particularly crucial given Fluconazole’s vital role in treating cryptococcal meningitis—a life-threatening condition affecting immunocompromised patients worldwide. With each step of our manufacturing process steeped in scientific rigor and ethical responsibility, Virupaksha stands at the forefront of pharmaceutical excellence, dedicated to making a profound impact on patient care globally.
Other Latest News
- Adnoc Distribution signs industrial partnership worth over $16m May 7, 2026 9:33 am Trade Arabia Adnoc Distribution has announced new strategic partnerships with Emirates Global Aluminium (EGA) and Borouge, collectively valued at over AED 60 million ($16 million), aimed at strengthening industrial performance and reinforcing the UAE’s manufacturing …
- SGS launches GMP-compliant NMR testing for Chinese pharma industry May 7, 2026 6:36 am Biospectrum Asia SGS launches GMP-compliant NMR testing for Chinese pharma industry May 7, 2026 | Thursday | News NMR delivers high-resolution structural clarity and quantitative precision SGS, world’s leading Testing, Inspection and Certification company, has expanded its …
- How India's pharmaceutical pipeline is fuelling West Africa's opioid crisis May 6, 2026 5:48 pm Yahoo Sports - Canada For more than a decade, a sizable chunk of West Africa – including Ghana, Sierra Leone, Senegal, Nigeria and Ivory coast – has been gripped by an opioid-abuse epidemic that has devastated families, killed thousands and strained an already overburdened …
- Full Transcript: Madrigal Pharmaceuticals Q1 2026 Earnings Call May 6, 2026 1:32 pm Benzinga Thanks everyone. Good morning everyone and thank you for joining us to discuss Madrigal's first quarter 2026 earnings. We issued a press release this morning and posted a slide deck to accompany this webcast on the Investor Relations section of our …
- NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA May 4, 2026 2:56 pm Knox County News - Nebraska SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on …
- Small Language Models trained for your industry can deliver more for your business May 4, 2026 12:39 pm TechRadar Pro Follow us Add us as a preferred source on Google Newsletter Subscribe to our newsletter Asked why he robbed banks, the American bank robber Willie Sutton is supposed to have answered, “because that’s where the money is.” It’s a limited point of view, but …
- Building quality into drug development for safer, faster medicines April 29, 2026 10:54 am Medical News In this interview, News Medical-Life Sciences speaks with Anil Kane, pharmaceutical development expert at Thermo Fisher Scientific’s Pharma Services Group, about how quality is built into Drug Development from early design through manufacturing. He …
- Piramal Pharma Limited Announces Results for Q4 and Full-year FY26 April 29, 2026 3:40 am Business Upturn MUMBAI, India, April 28, 2026 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) …
- <![CDATA[Pharmaceutical Executive Daily: FDA Approves Breztri]]> April 29, 2026 3:29 am Pharmaceutical Executive Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today's Pharmaceutical Executive Daily, a pharma M&A roundup covers two significant deals, Sun Pharma's $11 …
- Mark Cuban’s next target: Insurance companies April 28, 2026 6:06 pm Semafor Mark Cuban: I’ll give you the exact answer. Rohan Goswami: Yeah, tell me. Mark Cuban: The exact logic. I’m rich as (beep). I don’t need the money. Liz Hoffman: Welcome back to Compound Interest from Semafor Business. I’m Semafor’s business and finance …
- North Korean Hackers Target Pharma Firms with Malware-Laced Excel Attacks April 27, 2026 11:50 pm GBHackers North Korean state-backed hackers are using weaponized Excel-themed files to infect pharmaceutical and life science companies with malware, abusing Windows shortcut files, PowerShell, and cloud storage for stealthy data theft. The campaign begins with …
- Russell’s Teapot: Dispatches From the Final Stage of the AI Bubble April 27, 2026 11:58 am Institute for New Economic Thinking Frontier generative Artificial Intelligence (AI) companies are spending billions and billions of dollars on developing, training and running their algorithms, supposedly in pursuit of some notion of ‘superintelligence’. To sustain the hype and keep …
- Trends and Challenges in Nitrosamine Testing: Part Three – Building a Method April 25, 2026 1:04 am The Medicine Maker Credit: Pill image sourced from Adobe Stock If starting from scratch, how would you go about building a method for nitrosamine analysis? Alan Thompson: When starting from scratch, we would tend to exercise a methodical process as outlined below. This …
- Vistin Reports First Quarter 2026 Results April 24, 2026 6:47 pm RTTNews Vistin Pharma ASA (VISTN), a pharmaceutical manufacturing company, announced on Friday financial results for the first quarter of 2026. Vistin produces an estimated 10% of the world's metformin hydrochloride, an essential medication in the treatment …
- The best inventory management software of 2026: Expert tested and reviewed April 24, 2026 12:53 pm ZDNet If you're still managing inventory in spreadsheets (or worse, on paper), you already know how quickly things fall apart. One stockout during a busy sales week can cost you thousands. A single miscounted stock keeping unit, or SKU, can snowball into a …
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides April 22, 2026 10:10 am Investing News Network SHELTON, CT / ACCESS Newswire / April 21, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based …
- Business News | Morepen Labs' Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time April 20, 2026 7:00 am Latestly NewsVoir Gurugram (Haryana) [India], April 20: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has announced the successful completion of a USFDA (United States Food and Drug Administration) inspection at its Masulakhanna (Himachal) facility, …
- Business News | Rusan Pharma Achieves Global GMP Milestone with PMDA Japan Approval April 20, 2026 6:59 am Latestly VMPL Mumbai (Maharashtra) [India], April 20: Rusan Pharma, a leading pharmaceutical company pioneering pain management, movement disorder, and addiction solutions worldwide, has achieved a significant global regulatory milestone with the successful Good …
- <![CDATA[Haisco Enters $745 Million Exclusive License Agreement with AbbVie ]]> April 15, 2026 12:51 am Pharmaceutical Executive AbbVie announced a global licensing agreement with China-based Haisco Pharmaceutical to manufacture, commercialize, and develop novel medicines for the treatment of pain. Emerging Pharma Leaders nominations are now open! Do you know someone who can make …
- Brains Bioceutical Appoints Dr. Priyajit "Bobby" Prasad as Chairman of Medical Advisory Board April 14, 2026 10:32 am Voice of Alexandria - Minnesota VANCOUVER, Canada, April 14, 2026 (EZ Newswire) -- Brains Bioceutical Corp. ("Brains Bio"), a global life sciences company advancing a clinically validated portfolio of therapeutic and pharmaceutical programs, today announced the appointment of …
- Preparation is key to understanding global trade compliance for trials April 13, 2026 10:22 am Clinical Trials Arena For global studies, investigational material and active pharmaceutical ingredients (API) are often shipped to sites in different countries from a central manufacturing base. This means that tax or VAT must be paid on the product upon entry to each country …
- Trends and Challenges in Nitrosamine Testing: Part One – Scoping the Problem April 9, 2026 5:08 pm The Medicine Maker Kevin Parker is a Senior Scientist I, Analytical R&D, Small Molecule CMC Development, AbbVie Jessica Hoskins is a Principal Research Scientist I, Small Molecule Analytical R&D, Predictive Stability and Structure Elucidation, AbbVie Alan Thompson is …
- <![CDATA[US-Iran Ceasefire Offers Brief Stability for Global Pharma Supply Chains]]> April 8, 2026 10:28 pm Pharmaceutical Commerce The global pharmaceutical supply chain was granted a 14-day reprieve on April 7, 2026, after the US and Iran agreed to a Pakistani-mediated ceasefire just hours before a critical military deadline.1 The agreement marks a significant de-escalation in the …
- <![CDATA[Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report ]]> April 8, 2026 11:43 am Pharmaceutical Executive The ongoing military conflict between the U.S. and Iran affected global pharma supply chains, disrupted the transportation of key medicines, and raised concerns with drugmakers over the looming fallout of logistics. Emerging Pharma Leaders nominations are …
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides April 7, 2026 11:03 pm Investing News Network SHELTON, CT / ACCESS Newswire / April 7, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on …
- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocks April 6, 2026 5:48 am The Economic Times The US has imposed tariffs of up to 100% on patented pharmaceuticals, with significant carve-outs for generics, biosimilars, and major manufacturing hubs, leaving India's speciality drugmakers exposed while generic players remain unscathed. US …
- US imposes 15% tariff on Swiss pharma products April 3, 2026 3:16 pm Swissinfo USA imposes high pharmaceutical tariffs - 15 per cent rate for Switzerland Keystone-SDA American President Donald Trump has announced tariffs of up to 100% on the import of patented medicines into the US. According to a decree published by the White House …
- LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites March 19, 2026 11:58 am Voice of Alexandria - Minnesota BOCA RATON, Fla.--(BUSINESS WIRE)--Mar 19, 2026-- LGM Pharma, a leading provider of tailored API sourcing, contract analytical testing, and CDMO services for the full drug product lifecycle, today announced the second phase of its CDMO growth strategy, …
- Iran War Pushes Up Prices Of Raw Material In Pharma Industries: Will Vitamins, Antibiotics Be Costlier? March 12, 2026 5:35 pm News18 Last Updated:March 11, 2026, 06:30 IST The rise in raw material costs cannot immediately be passed on to patients as prices of many medicines in India are regulated by the National Pharmaceutical Pricing Authority Rapid Read Summarized by AI. + The ongoing …
- Top stocks in news: BEL, Dr Reddy's, Bajaj Auto, Jio Fin, GRSE, Mazagon, Tata Elxsi, Wipro March 6, 2026 5:49 am Business Today Indian benchmark indices settled sharply higher on Thursday amid supportive global cues including easing geopolitical concerns and value-buying in select pockets. The BSE Sensex zoomed 899.71 points, or 1.14 per cent, to settle at 80,015.90, while NSE' …